# Qbrexza

NDC: 69489-411
Generic name: glycopyrronium
Labeler / Manufacturer: Journey Medical Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CLOTH
Routes: TOPICAL
Marketing started: 20180628

FDA application: NDA210361

## Active ingredients

- GLYCOPYRRONIUM TOSYLATE: 2.4 g/100g

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"69489-411"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=69489-411
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5b372650-e56e-47a5-93e2-c0c292017059